191 related articles for article (PubMed ID: 11702597)
1. Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML.
Padua RA; McGlynn A; McGlynn H
Cancer Treat Res; 2001; 108():111-57. PubMed ID: 11702597
[TBL] [Abstract][Full Text] [Related]
2. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
3. MDS and secondary AML: an evolutionary perspective.
Audeh MW
Cancer Treat Res; 2001; 108():267-78. PubMed ID: 11702604
[No Abstract] [Full Text] [Related]
4. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
[TBL] [Abstract][Full Text] [Related]
6. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
[TBL] [Abstract][Full Text] [Related]
7. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
8. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 4 and ring chromosome in a patient with acute myelomonocytic leukemia.
Vicari L; Sebastio L; Stanziola MC; Fasanaro A; Ferrara F
Haematologica; 1994; 79(1):83-5. PubMed ID: 15378955
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
[TBL] [Abstract][Full Text] [Related]
11. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.
Lezon-Geyda K; Najfeld V; Johnson EM
Leukemia; 2001 Jun; 15(6):954-62. PubMed ID: 11417483
[TBL] [Abstract][Full Text] [Related]
12. C/EBP-epsilon: chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia.
Koike M; Chumakov AM; Takeuchi S; Tasaka T; Yang R; Nakamaki T; Tsuruoka N; Koeffler HP
Leuk Res; 1997 Sep; 21(9):833-9. PubMed ID: 9393598
[TBL] [Abstract][Full Text] [Related]
13. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia.
Maciejewski JP; Risitano A; Sloand EM; Nunez O; Young NS
Blood; 2002 May; 99(9):3129-35. PubMed ID: 11964274
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal rearrangements in childhood acute myeloid leukemia and myelodysplastic syndromes.
Martinez-Climent JA; García-Conde J
J Pediatr Hematol Oncol; 1999; 21(2):91-102. PubMed ID: 10206454
[TBL] [Abstract][Full Text] [Related]
15. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration.
Paulsson K; Heidenblad M; Strömbeck B; Staaf J; Jönsson G; Borg A; Fioretos T; Johansson B
Leukemia; 2006 May; 20(5):840-6. PubMed ID: 16498392
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes: preleukemic syndromes].
Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
[TBL] [Abstract][Full Text] [Related]
17. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci.
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1993 Dec; 8(4):205-18. PubMed ID: 7512363
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of cytogenetics in leukemias.
VinSheth FJ; Sheth JJ; Patel AI; Shah AD; Verhest A
Indian J Cancer; 2002; 39(4):139-42. PubMed ID: 12928572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
